Adrien N.
- Country
- France
- Department
- Gastroenterology
Research Overview
- Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Duvakitug for Induction Therapy in Moderately to Severely Active Crohn's Disease
- Efficacy and Safety of Duvakitug for Maintenance Therapy in Participants with Moderately to Severely Active Crohn’s Disease: A Phase 3, Randomized, Placebo-Controlled Study
- Long-term Safety, Tolerability, and Efficacy of Balinatunfib in Adults with Crohn's Disease or Ulcerative Colitis: A Multicenter Extension Study
Data & Insights
Has run more than one trial at 469 of 654 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating complex inflammatory bowel conditions, with particular focus on both Crohn's disease and ulcerative colitis.
- Moderate to severe disease manifestations
- Treatment-resistant cases
- Long-term disease management
The investigator's work encompasses evaluating novel therapeutic approaches for patients who have not responded adequately to conventional treatments.
Innovative Therapeutics
Expertise in investigating emerging targeted therapies including obefazimod, zasocitinib, and eltrekibart for inflammatory bowel conditions.
- Novel therapeutic compounds
- Combined treatment approaches
- Maintenance therapy optimization
The investigator explores both single-agent and combination therapeutic strategies for achieving optimal clinical outcomes.
Clinical Efficacy Assessment
Focused on evaluating the effectiveness of advanced therapies through comprehensive assessment of clinical remission and endoscopic response.
- Treatment response monitoring
- Long-term safety evaluation
- Therapeutic drug monitoring
The investigator's work includes systematic assessment of both short-term and extended therapeutic outcomes in inflammatory bowel conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.